Inhibition by vitamins C and E of in vivo nitrosation and vitamin C occurrence in the stomach

European Journal of Cancer Prevention

Volumn 5, Issue SUPPL. 1, 1996, Pages 131-136

  Mirvish, S S ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; NITROSO DERIVATIVE;

CANCER; CANCER INHIBITION; CONFERENCE PAPER; HUMAN; NITROSATION; PRIORITY JOURNAL; STOMACH;

ASCORBIC ACID; DIET; FRUIT; HUMANS; NITROSATION; NITROSO COMPOUNDS; STOMACH NEOPLASMS; VITAMIN E;

EID: 0030474142     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199609001-00027     Document Type: Conference Paper

References (37)

1. Bartsch H, Ohshima H, Pignatelli B, Calmels S (1989). Human exposure to endogenous N.-nitroso compounds: quantitative estimates in subjects at high risk for cancer of the oral cavity, oesophagus, stomach and urinary bladder. Cancer Surv 8: 335-62.
2. Bendich A (1995). Criteria for determining recommended dietary allowances for healthy older adults. Nutr Rev 53 (Suppl): S105-10.
3. Block G (1991). Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr 53: 270S-82S.
4. Cooney RV, Franke AA, Harwood PJ et al (1993). γ-Tocopherol detoxification of nitrogen dioxide: superiority to α-tocopherol. Proc Natl Acad Sci USA 90: 1771-5.
5. 2 and their formation in rat insulinoma (RINm5F) cells. Free Rad Biol Med 19: 259-69.
6. Correa P, Fontham ETH, Ruiz B et al (1995). Gastric juice ascorbic acid after intravenous injection: effect of ethnicity, pH and Helicobacter pylori infection. J Natl Cancer Inst 87: 52-3.
7. Helser MA, Hotchkiss JH (1994). Comparison of tomato phenolic and ascorbate fractions on the inhibition of N.-nitroso compound formation. J Agric Food Chem 42: 129-32.
8. Helser MA, Hotchkiss JH, Roe DA (1991). Temporal influence of ascorbic acid dose on the endogenous formation of N.-nitrosoproline and N′-nitrosothiazolidine-4-carboxylic acid in humans. J Nutr Biochem 2: 268-73.
9. Helser MA, Hotchkiss JH, Roe DA (1992). Influence of fruit and vegetable juices on the endogenous formation of N.-nitrosoproline and N.-nitrosothiazolidine-4-carboxylic acid in humans on controlled diets. Carcinogenesis 1: 2-3.
10. Hensen DE, Block G, Levine M (1991). Ascorbic acid: biologic functions and relation to cancer. J Natl Cancer Inst 83: 547-50.
11. Iqbal AM, Epstein SS, Krull IS et al (1980). Kinetics of nitrosamine formation in mice following oral administration of trace-level precursors. In N-Nitroso Compounds: Analysis, Formation and Occurrence, eds EA Walker, L Griciute, M Castignaro, M Borzsonyi and W Davis, IARC Scientific Publication no. 31, IARC, Lyon, pp. 169-82.
12. Jacob RA, Skala JH, Omaye ST (1987). Biochemical indices of human vitamin C status. Am J Clin Nutr 46: 818-26.
13. Leaf CD, Vecchio AJ, Roe DA, Hotchkiss JH (1987). Influence of ascorbic acid dose on N.-nitrosoproline formation in humans. Carcinogenesis 8: 791-5.
14. Lennard-Jones JE, Babouris N (1965). Effect of different foods on the acidity of the gastric contents in patients with duodenal ulcer. Gut 6: 113-7.
15. MacGregor IL, Martin P, Meyer JH (1977). Gastric emptying of solid food in normal man and after subtotal gastrectomy and truncal vagotomy with pyloroplasty. Gastroenterology 72: 206-11.
16. Mergens WJ, Kamm JJ, Newmark HL (1978). Alpha-tocopherol: uses in preventing nitrosamine formation. In Environmental Aspects of N-Nitroso Compounds, eds EA Walker, L Griciute, M Castegnaro, RE Lyle and W Davis, IARC Scientific Publication no. 19, IARC, Lyon, pp. 199-212.
17. Mirvish SS (1975). Formation of N.-nitroso compounds: chemistry, kinetics and in vivo occurrence. Toxicol Appl Pharmacol 31: 325-51.
18. Mirvish SS (1980). Ascorbic acid inhibition of N.-nitroso compound formation in chemical, food and biological systems. In Inhibition of Tumor Induction and Development (eds Zedeck MS, Lipkin M); Plenum Press, New York, pp. 101-26.
19. Mirvish SS (1981). Inhibition of the formation of carcinogenic N.-nitroso compounds by ascorbic acid and other compounds. In Cancer 1980: Achievements, Challenges, Prospects for the 1980s (eds Burchenal JH, Oettgen HF); Grune and Stratton, New York, pp. 557-87.
20. Mirvish SS (1983). The etiology of gastric cancer: intragastric nitrosamide formation and other theories. J Natl Cancer Inst 71: 629-47.
21. Mirvish SS (1986). Effects of vitamins C and E on N′-nitroso compound formation, carcinogenesis and cancer. Cancer 58: 1842-50.
22. Mirvish SS (1994). Experimental evidence for inhibition of N.-nitroso compound formation as a factor in the negative correlation between vitamin C consumption and the incidence of certain cancers. Cancer Res 54 (Suppl): 1948s-51s.
23. Mirvish SS (1995). Role of N.-nitroso compounds (NOC) in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 93: 17-48.
24. Mirvish SS, Grandjean AC, Moller H et al (1992). N-nitrosoproline excretion by rural Nebraskans drinking water of varied ntirate content. Cancer Epidemiol Biomarkers Prev 1: 455-61.
25. Mirvish SS, Grandjean AC, Reimers KJ et al (1995). Dosing time with ascorbic acid and nitrate, chewing gum and tobacco, chewing, fasting and other factors affecting N-nitrosoproline formation in healthy subjects taking proline with a standard meal. Cancer Epidemiol Biomark Prev 4: 775-82.
26. Mordan LJ, Burnett TS, Zhang L-X, Tom J, Cooney RV (1993). Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts. Carcingoenesis 14: 1555-9.
27. National Academy of Sciences (1981). The Health Effects of Nitrate, Nitrite und N-Nitroso Compounds. National Academy Press, Washington, DC.
28. O'Connor HJ, Schorah CJ, Habibzedah N, Axon AT-R, Cockel R (1989). Vitamin C in the human stomach: relation to gastric-pH, gastroduodenal disease and possible sources. Gut 30: 436-42.
29. Rathbone BJ, Johnson AW, Wyatt JI et al (1989). Ascorbic acid: a factor concentrated in human gastric juice. Clin Sci 76: 237-41.
30. Rood JC, Ruiz B, Fontham ETH et al (1994). Helicobacter pylori-associated gastritis and the ascorbic acid concentration in gastric juice. Nutr Cancer 22: 65-72.
31. Ruiz B, Correa P, Fontham ETH et al (1994). Ascorbic acid, Helicobacter pylori and Lewis phenotype among blacks and whites in New Orleans. Cancer Lett 83: 323-9.
32. Sauberlich HE (1975). Vitamin C status: methods and findings. Ann NY Acad Sci 250: 438-50.
33. Sauberlich HE (1994). Pharmacology of vitamin C. Ann Rev Nutr 14: 371-91.
34. Sobala GM, Schorah CJ, Sanderson M et al (1989). Ascorbic acid in the human stomach. Gastroenterology 97: 357-63.
35. Sobala GM, Crabtree JE, Dixon MF et al (1991). Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology and gastric juice ascorbic acid concentrations. Gut 32: 1415-8.
36. Wefers H, Sies H (1988). The protection by ascorbate and glutathione against microsomal lipid peroxidation dependent on vitamin E. Eur J Biochem 174: 353-7.
37. Xu GP, Reed PI (1993). N′-Nitroso compounds in fresh gastric juice and their relation to intragastric pH and nitrite employing an improved analytical method. Carcinogenesis 14: 2547-51.